Godavari Biorefineries (GODAVARIB) Q2 FY27 Loss Narrows as Chemicals Drive a Turnaround
The biorefinery's revenue grew 27.5% year-on-year, with its bio-based chemicals segment powering an operational profit, though high costs kept the bottom line in the red.
Godavari Biorefineries' Q2 FY27 saw revenue surge 27.5% YoY to ₹549.24 crore, while its net loss narrowed by 63.4%. The bio-based chemicals segment was the key driver, turning operating profit positive for the quarter.
For Godavari Biorefineries, the path to profitability runs through its chemical labs. The September quarter showed a company in transition, where a booming specialty business is trying to offset the deep-seated challenges of sugar and ethanol.
Revenue rose 27.5% year-on-year to ₹549.24 crore, but a net loss of ₹15.24 crore persisted. The story is in the margins: the net loss narrowed by 63.4% from a year ago, and the operating line finally turned positive.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 549.24YoY +28% | 557.88 | 430.75 |
| Profit (₹ Cr) | -15.24YoY +63% | -19.32 | -41.59 |
| Net Profit Margin | -2.8%YoY +71% | -3.5% | -9.7% |
Why the loss narrowed
The improvement stemmed from a powerful shift in the business mix. According to reports from scanx.trade and tradealone.com, the Bio-based Chemicals segment was the star. Its revenue grew about 39% year-on-year, with segment EBITDA surging roughly 47%.
This segment contributed an operating profit of ₹18.77 crore, as noted by Multibagg.ai. It acted as a buffer against the integrated sugar and ethanol division, which continued to report losses due to high input costs and challenging feedstock conditions.
The costs that won't go away
Despite the top-line growth, profitability was capped by persistent cost pressures. The cost of materials consumed surged to ₹220.39 crore from ₹146.21 crore a year earlier, as per scanx.trade. Finance charges also rose 25% year-on-year.
These elevated costs, coupled with a sharp 85% drop in other income, kept the company in the red at the net level. The interest cover remains thin at 1.09, highlighting the strain from its ₹531 crore debt load.
A policy cloud over ethanol
The outlook for the ethanol business, a core segment, faces a new headwind. A report in The Telegraph notes that India's ethanol blending rate may fall below the 20% target this supply year due to poor monsoon-hit crops.
The government has directed oil companies not to procure ethanol from sugar-based feedstocks for the new season. This policy shift prioritizes food security and creates uncertainty for distillery offtake, though Godavari's new grain-based capacity offers some flexibility.
Key Points
- Revenue growth of 27.5% was driven by strong volume increases in the sugar and bio-based chemicals segments.
- The Bio-based Chemicals division was the profit engine, with revenue up ~39% YoY and segment EBITDA rising ~47%.
- High raw material costs and finance charges prevented the operating profit turnaround from reaching the net profit line.
- Government policy shifts on ethanol blending and feedstock procurement add uncertainty to the core distillery business.
Hexa Perspective
The quarter confirms Godavari's strategic pivot is gaining traction. The bio-based chemicals arm is delivering the margin expansion and growth needed to change the company's profile.
Yet, the journey is incomplete. The sugar and ethanol operations remain a drag, susceptible to volatile commodity prices and now shifting government policy. The company's elevated debt and thin interest cover mean the margin for error is slim. The next few quarters will test whether chemical profits can grow fast enough to consistently outweigh the legacy business's costs and finally deliver sustained net profitability.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
